Ipilimumab and Nivolumab in Advanced Hepatocellular Carcinoma after Failure of Prior Immune Checkpoint Inhibitor-Based Combination Therapies: a Multicenter Retrospective Study
Journal of Cancer Research and Clinical Oncology(2022)
关键词
Atezolizumab,Bevacizumab,Immune checkpoint inhibitors,Hepatocellular carcinoma,Ipilimumab,Nivolumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要